SUMMARY

Pharmaceutical companies are under increasing pressure to reduce costs, speed the time-to-market for new products and ensure that physicians are informed and educated about their products.

Traditional interaction methods, however, are becoming less effective as the quality of interactions between physicians and pharmaceutical representatives have decreased. Brand marketing managers are looking to augment traditional offerings with non-personal selling technologies to reach new segments or healthcare professionals.

MERGE Rx recognizes these changes and offers a new generation of Web-enabled software that helps pharmaceutical companies manage physician interactions—including key opinion leader (KOL) management, phaseIV trials, and eDetailing—from a single, secure and scalable access point.

Topics and issues covered include:

• Marketing Mix Shift
• Other Landscape Changes
• Eight Great Ways to Improve Interactions
• Multi-Channel Non Personal Interactions
• eDetailing
• Personalization
• Key Opinion Leader Management